Arkolith/Insider Trading/IMMX/Form 4

Morris Gabriel S

CFO, DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Dec 10, 2025
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2025Buy(P)770$6.58$5K291K
Dec 8, 2025Option exercise(X)156K$0.80$125K427K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 8, 2025Option exercise(X)96K—$00
Dec 8, 2025Option exercise(X)60K—$00

Transaction Codes

P
Open-market purchase
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-027107) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Immix Biopharma, Inc.

Build

Ask your agent about IMMX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-25-027107"
Ask your agent
Use Arkolith to summarize insider buying and selling at Immix Biopharma, Inc.
over the last 90 days and cite the filings.